Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments

Bladder cancer is the sixth most common malignancy in the United States and 70% of cases are non-muscle invasive at the time of diagnosis. Effective treatment is crucial to prevent progression, which occurs in about 30% of patients. The American Urological Association (AUA) guidelines recommend trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Ilana P., Lichtbroun, Benjamin, Singer, Eric A., Ghodoussipour, Saum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431226/
https://www.ncbi.nlm.nih.gov/pubmed/36051251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431226/
https://www.ncbi.nlm.nih.gov/pubmed/36051251

Ejemplares similares